University of South Alabama
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of South Alabama sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
University of South Alabama: 17 sponsored US clinical trials, 1 recruiting.
University of South Alabama sponsors 17 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 9 completed. 4 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
University of South Alabama ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
9 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (60.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
NCT06467695
Comparing Intramuscular Fentanyl and Ketorolac With Nerve of Arnold (NOA) Block for Bilateral Myringotomy
NCT07276906
Impact of a Cueing Device on Upper Extremity Muscle Strength in Swimmers
NCT06923930
Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity
NCT06214468
Does Steroid Plus CO2 Laser Improve Lichen Sclerosus Symptoms Compared to Steroids Alone?
NCT05243563
Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause
NCT04841499
Trial of Hydroxychloroquine In Covid-19 Kinetics
NCT04353271
Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer
NCT04230954
Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
NCT03701074
A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus
NCT01787656
Vascular Endothelium Changes After Bariatric Surgery (Endothelial Progenitor Cells)
NCT01213940
Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating Medications
NCT01096290
Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
NCT01322035
Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy
NCT00746395
Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
NCT00634972
Using a Voice Output Communication Aid to Facilitate Language Development in Young Children With ASD
NCT01816178
Biomagnetic Signals of Intestinal Ischemia
NCT00285545
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
| Phase 4 | 4 |
What is open in the University of South Alabama pipeline
1 recruiting of 17 indexed (6% open); 9 completed (53%).
Phase mix: 4 late (III/IV) vs 5 early (I/II) (balanced across stages).
Therapeutic area indexing for this sponsor is limited in the public registry.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of South Alabama: open-pipeline peers nationwide
Peers matched on 17 registered trials and 6% open enrollment, not the therapeutic-area sidebar.
University of South Alabama sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 6% open enrollment (± trial volume)
- Colgate Palmolive · 6% recruiting · 51 trials
- Durham VA Medical Center · 6% recruiting · 17 trials
- Essentia Health · 6% recruiting · 17 trials
- Madrigal Pharmaceuticals · 6% recruiting · 17 trials
Related
What to do with this University of South Alabama page
17 registered trials is a research-attention snapshot, not an endorsement of University of South Alabama or any single study.
- 1 of University of South Alabama's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of South Alabama pipeline card: 17 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.